These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16412842)

  • 1. Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst.
    Bustos JA; Pretell EJ; Llanos-Zavalaga F; Gilman RH; Del Brutto OH; Garcia HH;
    Clin Neurol Neurosurg; 2006 Feb; 108(2):193-4. PubMed ID: 16412842
    [No Abstract]   [Full Text] [Related]  

  • 2. Short course of albendazole therapy for neurocysticercosis.
    Alarcón F; Maldonado JC
    Clin Neurol Neurosurg; 2006 Dec; 108(8):810-1. PubMed ID: 16647198
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial.
    Kalra V; Dua T; Kumar V
    J Pediatr; 2003 Jul; 143(1):111-4. PubMed ID: 12915835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis.
    Singhi P; Jain V; Khandelwal N
    J Child Neurol; 2004 May; 19(5):323-7. PubMed ID: 15224704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of 52 cases of neurocysticercosis.
    Chaoshuang L; Zhixin Z; Xiaohong W; Zhanlian H; Zhiliang G
    Trop Doct; 2008 Jul; 38(3):192-4. PubMed ID: 18628562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial.
    Singhi P; Dayal D; Khandelwal N
    Pediatr Infect Dis J; 2003 Mar; 22(3):268-72. PubMed ID: 12634590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis].
    Guo DM; Xie SP; Jia JP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(3):187-8. PubMed ID: 14628357
    [No Abstract]   [Full Text] [Related]  

  • 8. Monocular blindness during therapy for cerebral neurocysticercosis.
    Sundar U; Chawla V; Lakkas Y; Shrivastava M; Asole D; Vaidy M
    J Assoc Physicians India; 2010 Sep; 58():570-2. PubMed ID: 21391379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocysticercosis.
    Lev N; Michowiz S; Inbar E; Coire CI; Pitlik S; Melamed E
    Isr Med Assoc J; 2002 Jan; 4(1):65-6. PubMed ID: 11802316
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.
    Cangalaya C; Bustos JA; Calcina J; Vargas-Calla A; Mamani J; Suarez D; Arroyo G; Gonzalez AE; Chacaltana J; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005624. PubMed ID: 28575043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden-onset ptosis caused by midbrain neurocysticercosis in 2 children.
    Singhi P; Mahajan V; Khandelwal NK
    J Child Neurol; 2008 Mar; 23(3):334-7. PubMed ID: 18192649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albendazole therapy for solitary persistent cysticercus granuloma.
    Thussu A; Arora A; Lal V; Prabhakar S; Sawhney IM
    Neurol India; 2001 Mar; 49(1):95-7. PubMed ID: 11303254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel therapy in neurocysticercosis.
    Gogna A
    J Assoc Physicians India; 1996 Feb; 44(2):149. PubMed ID: 10999076
    [No Abstract]   [Full Text] [Related]  

  • 14. Three-day versus 15-day course of albendazole therapy in solitary cysticercus granuloma: an open label randomized trial.
    Khurana N; Garg RK; Verma R; Malhotra HS; Singh MK; Shukla R
    J Neurol Sci; 2012 May; 316(1-2):36-41. PubMed ID: 22342396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of lesion load and efficacy of 3 cycles of albendazole in disseminated cysticercosis: a prospective evaluation.
    Pandey S; Malhotra HS; Garg RK; Malhotra KP; Kumar N; Rizvi I; Jain A; Kohli N; Verma R; Sharma P; Uniyal R; Pandey S
    BMC Infect Dis; 2020 Mar; 20(1):220. PubMed ID: 32171260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.
    Göngora-Rivera F; Soto-Hernández JL; González Esquivel D; Cook HJ; Márquez-Caraveo C; Hernández Dávila R; Santos-Zambrano J
    Neurology; 2006 Feb; 66(3):436-8. PubMed ID: 16382035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for neurocysticercosis.
    Takayanagui OM
    Expert Rev Neurother; 2004 Jan; 4(1):129-39. PubMed ID: 15853623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-day praziquantel versus 1-week albendazole for neurocysticercosis.
    Del Brutto OH; Campos X; Sánchez J; Mosquera A
    Neurology; 1999 Mar; 52(5):1079-81. PubMed ID: 10102436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions.
    Pretell EJ; García HH; Gilman RH; Saavedra H; Martinez M;
    Clin Neurol Neurosurg; 2001 Oct; 103(3):175-7. PubMed ID: 11532559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.